The cardiovascular effects of two new triazine antimalarials, BRL 50216 (Clociguanil) and BRL 6231M.J. Nettleton; R.H. Poyser; J.H. Shorter · 1974

CCCCXXVII.?Attempts to find new antimalarials. Part VII. Quinoline compounds having in the 4-position a side chain containing two or more nitrogen atomsKermack, William Ogilvy; Smith, James Fergus · Journal of the Chemical Society (Resumed) · 1931

Computer model accurately predicts chemotherapy responseInpharma Weekly · 2006

AzodicarbonamideInpharma Weekly · 1999

Recommendations for treatment of severe aplastic anaemiaInpharma Weekly · 1994

Did you know about R&D costs?Inpharma Weekly · 1993

R&D investment in JapanInpharma Weekly · 1993

NICE creates new R&D committeeInpharma Weekly · 2003

Gallic acid has potential in lung cancerInpharma Weekly · 2002

New mesalazine formulation advantageous in IBDInpharma Weekly · 2001